China National Medicines Corporation Ltd. (600511.SS)
CNY 34.43
(1.89%)
CNY 34.43
(1.89%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.82 Billion CNY | -14.78% |
| 2022 | 2.9 Billion CNY | 7.27% |
| 2021 | 2.66 Billion CNY | 23.87% |
| 2020 | 2.14 Billion CNY | -16.94% |
| 2019 | 2.6 Billion CNY | 18.98% |
| 2018 | 2.03 Billion CNY | 18.96% |
| 2017 | 1.87 Billion CNY | 145.86% |
| 2016 | 1.65 Billion CNY | 4.94% |
| 2015 | 706.86 Million CNY | -6.17% |
| 2014 | 794.72 Million CNY | 31.7% |
| 2013 | 499.88 Million CNY | 20.32% |
| 2012 | 408.42 Million CNY | 19.82% |
| 2011 | 400.56 Million CNY | -5.98% |
| 2010 | 447.47 Million CNY | 54.38% |
| 2009 | 280.75 Million CNY | -2.73% |
| 2008 | 294.99 Million CNY | 24.2% |
| 2007 | 226.17 Million CNY | 68.71% |
| 2006 | 142.26 Million CNY | 42.47% |
| 2005 | 99.88 Million CNY | 38.93% |
| 2004 | 71.9 Million CNY | 6.84% |
| 2003 | 67.29 Million CNY | 26.33% |
| 2002 | 53.26 Million CNY | 24.05% |
| 2001 | 42.94 Million CNY | 34.74% |
| 2000 | 31.87 Million CNY | 40.31% |
| 1999 | 22.71 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 616.7 Million CNY | -0.67% |
| 2024 Q1 | 655.18 Million CNY | -21.02% |
| 2024 Q3 | 656.7 Million CNY | 6.49% |
| 2023 Q2 | 784.24 Million CNY | 28.88% |
| 2023 Q1 | 608.51 Million CNY | -19.53% |
| 2023 FY | - CNY | -14.78% |
| 2023 Q4 | 786.1 Million CNY | 10.66% |
| 2023 Q3 | 710.4 Million CNY | -9.42% |
| 2022 Q3 | 814.49 Million CNY | 18.56% |
| 2022 Q1 | 575.22 Million CNY | -11.75% |
| 2022 Q4 | 756.21 Million CNY | -7.16% |
| 2022 FY | - CNY | 7.27% |
| 2022 Q2 | 686.97 Million CNY | 19.43% |
| 2021 Q3 | 819.73 Million CNY | 12.73% |
| 2021 FY | - CNY | 23.87% |
| 2021 Q2 | 727.17 Million CNY | 65.19% |
| 2021 Q1 | 440.2 Million CNY | -17.51% |
| 2021 Q4 | 651.78 Million CNY | -20.49% |
| 2020 Q2 | 583.16 Million CNY | 65.37% |
| 2020 Q4 | 533.63 Million CNY | -15.65% |
| 2020 FY | - CNY | -16.94% |
| 2020 Q1 | 352.65 Million CNY | -57.03% |
| 2020 Q3 | 632.68 Million CNY | 8.49% |
| 2019 Q2 | 781.6 Million CNY | 81.62% |
| 2019 Q1 | 430.36 Million CNY | -34.69% |
| 2019 Q4 | 820.64 Million CNY | 53.63% |
| 2019 FY | - CNY | 18.98% |
| 2019 Q3 | 534.16 Million CNY | -31.66% |
| 2018 Q2 | 648.56 Million CNY | 67.92% |
| 2018 Q3 | 521 Million CNY | -19.67% |
| 2018 Q1 | 386.24 Million CNY | -39.62% |
| 2018 Q4 | 658.92 Million CNY | 26.47% |
| 2018 FY | - CNY | 18.96% |
| 2017 Q4 | 639.64 Million CNY | 28.28% |
| 2017 Q1 | 171.88 Million CNY | -30.7% |
| 2017 Q2 | 677.37 Million CNY | 294.08% |
| 2017 Q3 | 498.62 Million CNY | -26.39% |
| 2017 FY | - CNY | 145.86% |
| 2016 FY | - CNY | 4.94% |
| 2016 Q2 | 238.69 Million CNY | 58.45% |
| 2016 Q1 | 150.64 Million CNY | -47.69% |
| 2016 Q4 | 248.03 Million CNY | 38.41% |
| 2016 Q3 | 179.2 Million CNY | -24.92% |
| 2015 Q4 | 287.99 Million CNY | 91.7% |
| 2015 FY | - CNY | -6.17% |
| 2015 Q3 | 150.23 Million CNY | -38.61% |
| 2015 Q2 | 244.7 Million CNY | 112.19% |
| 2015 Q1 | 115.32 Million CNY | -66.93% |
| 2014 FY | - CNY | 31.7% |
| 2014 Q2 | 252.91 Million CNY | 163.5% |
| 2014 Q1 | 95.98 Million CNY | -58.81% |
| 2014 Q4 | 348.68 Million CNY | 128.73% |
| 2014 Q3 | 152.44 Million CNY | -39.73% |
| 2013 Q3 | 152.54 Million CNY | -23.47% |
| 2013 Q2 | 199.34 Million CNY | 140.41% |
| 2013 Q1 | 82.91 Million CNY | -67.5% |
| 2013 FY | - CNY | 20.32% |
| 2013 Q4 | 233.03 Million CNY | 52.76% |
| 2012 Q4 | 255.14 Million CNY | 144.92% |
| 2012 Q1 | 81.28 Million CNY | -41.64% |
| 2012 Q2 | 158.28 Million CNY | 94.72% |
| 2012 Q3 | 104.17 Million CNY | -34.19% |
| 2012 FY | - CNY | 19.82% |
| 2011 FY | - CNY | -5.98% |
| 2011 Q1 | 91.93 Million CNY | -40.27% |
| 2011 Q4 | 139.28 Million CNY | 42.68% |
| 2011 Q3 | 97.62 Million CNY | -27.91% |
| 2011 Q2 | 135.42 Million CNY | 47.31% |
| 2010 Q4 | 153.91 Million CNY | 50.33% |
| 2010 FY | - CNY | 54.38% |
| 2010 Q3 | 102.38 Million CNY | 20.16% |
| 2010 Q2 | 85.2 Million CNY | -4.25% |
| 2010 Q1 | 88.99 Million CNY | 227.4% |
| 2009 Q1 | 80.47 Million CNY | -10.43% |
| 2009 Q4 | 27.18 Million CNY | -66.99% |
| 2009 FY | - CNY | -2.73% |
| 2009 Q3 | 82.34 Million CNY | -16.55% |
| 2009 Q2 | 98.67 Million CNY | 22.62% |
| 2008 FY | - CNY | 24.2% |
| 2008 Q4 | 89.84 Million CNY | 41.9% |
| 2008 Q3 | 63.32 Million CNY | -23.2% |
| 2008 Q2 | 82.44 Million CNY | 15.55% |
| 2008 Q1 | 71.34 Million CNY | 55.15% |
| 2007 Q4 | 45.98 Million CNY | -23.83% |
| 2007 Q1 | 60.77 Million CNY | 52.83% |
| 2007 Q2 | 53.95 Million CNY | -11.22% |
| 2007 FY | - CNY | 68.71% |
| 2007 Q3 | 60.37 Million CNY | 11.89% |
| 2006 Q1 | 32.17 Million CNY | -4.43% |
| 2006 FY | - CNY | 42.47% |
| 2006 Q4 | 39.76 Million CNY | 13.74% |
| 2006 Q3 | 34.96 Million CNY | -26.9% |
| 2006 Q2 | 47.82 Million CNY | 48.67% |
| 2005 FY | - CNY | 38.93% |
| 2005 Q4 | 33.66 Million CNY | 57.72% |
| 2005 Q1 | 25.73 Million CNY | 42.92% |
| 2005 Q3 | 21.34 Million CNY | -29.76% |
| 2005 Q2 | 30.38 Million CNY | 18.1% |
| 2004 Q4 | 18 Million CNY | -3.97% |
| 2004 Q3 | 18.74 Million CNY | 15.24% |
| 2004 FY | - CNY | 6.84% |
| 2004 Q2 | 16.26 Million CNY | -23.81% |
| 2004 Q1 | 21.35 Million CNY | 5.94% |
| 2003 Q2 | 17.67 Million CNY | -3.94% |
| 2003 Q1 | 18.39 Million CNY | 57.57% |
| 2003 FY | - CNY | 26.33% |
| 2003 Q4 | 20.15 Million CNY | 40.07% |
| 2003 Q3 | 14.38 Million CNY | -18.59% |
| 2002 Q4 | 11.67 Million CNY | 4.8% |
| 2002 Q3 | 11.14 Million CNY | -37.72% |
| 2002 FY | - CNY | 24.05% |
| 2002 Q2 | 17.88 Million CNY | 143.71% |
| 2002 Q1 | 7.34 Million CNY | 0.0% |
| 2001 FY | - CNY | 34.74% |
| 2000 FY | - CNY | 40.31% |
| 1999 FY | - CNY | 0.0% |